Description

Clozapine Tablets

Clozapine Tablets USP / BP / IP (25 mg / 50 mg / 100 mg)

High-Potency Dibenzodiazepine Atypical Antipsychotic

Healthy Life Pharma Private Limited, alongside our specialized global export and marketing division Healthy Inc, is an authorized manufacturer, CDMO services provider, and wholesale exporter of advanced neurological, psychiatric, and central nervous system (CNS) therapeutics. We manufacture ultra-high-purity, structurally uniform Clozapine Tablets within our state-of-the-art, WHO–GMP certified, high-containment psychotropic production facilities.

Serving as the critical frontline choice for refractory psychiatric conditions, this specialized neuroleptic represents an essential strategic export for mental health asylum networks, national public hospital reserves, health ministry psychiatric tenders, and digital B2B pharmaceutical marketplaces across the CIS region, Sub-Saharan Africa, LATAM, and South-East Asia.

Product Overview

This formulation operates as a “Selective Multi-Receptor Neuro-Modulator.” It ensures patient safety and psychological stabilization in severe refractory psychoses by executing a highly distinct, weak dopamine-blockade paired with strong serotonin-pathway regulation to rebalance chaotic neural signaling.

• Mechanism 1 (Balanced Dopaminergic Disengagement): Unlike standard neuroleptics that cause rigid motor side effects by tightly locking onto dopamine receptors, Clozapine exhibits a unique, low-affinity binding profile to Dopamine $\text{D}_{2}$ receptors in the mesolimbic pathway, physically disengaging rapidly to prevent extrapyramidal motor defects.

• Mechanism 2 (Serotonergic $\text{5-HT}_{2\text{A}}$ Antagonism): It acts as a powerful antagonist at Serotonin $\text{5-HT}_{2\text{A}}$ receptors. This specific chemical blockade increases dopamine release in the prefrontal cortex, transforming the management of negative symptoms (such as social withdrawal and emotional flattening).

• Mechanism 3 (Broad-Spectrum Neuromodulation Resonance): Concurrently, it displays high affinity and antagonistic actions across Dopamine $\text{D}_{4}$ and $\text{D}_{1}$ positions, Serotonin $\text{5-HT}_{1\text{A}/\text{2C}/\text{6}/\text{7}}$ anchors, Alpha-adrenergic targets, and Histamine $\text{H}_{1}$ switches, effectively dampening hyperactive, treatment-resistant hallucinations and suicidal behaviors.

Product Composition & Available Titration Strengths

Because Clozapine demands highly delicate, low-dose initial titration to protect the patient’s cardiovascular profile, we manufacture the full compendial strength spectrum.

Technical & Logistics Specifications

• HS Code: 3004.90.99 (Medicaments acting on the central nervous system / Psychotropics / Antipsychotics)

• CAS Number: 5786-21-0 (Clozapine)

• Dosage Form: Oral Solid Tablet (Compressed with distinct cross-scores to allow safe, highly accurate dosage fractioning)

• Packaging Configurations: 10 / 14 / 15 / 30 Tablets per Blister Strip packed exclusively in high-barrier Alu-Alu (Cold-Form Foil) or light-resistant deep-amber PVC/PVDC strips. Clozapine is physically sensitive to atmospheric moisture and photo-degradation; our premium tropicalized packaging completely shields the active core matrix, guaranteeing a stable 36-month shelf life in hot, humid Zone IVb export environments.

Psychotropic Manufacturing Governance & Quality Control

• Schedule X Air-Containment Isolation: Clozapine is an exceptionally potent psychiatric agent operating at low mass thresholds. To satisfy rigid international B2B regulatory audits, our tableting lines run inside Dedicated, Negative-Pressure Cleanroom Suites. Independent, HEPA-filtered HVAC infrastructures physically isolate these blocks to guarantee absolute zero active cross-contamination.

• Multi-Stage Geometric Blending Precision: Because active Clozapine constitutes a narrow percentage of the total tablet weight matrix in 25 mg strengths, we deploy Automated Multi-Stage Geometric Solid Blending Suites, physically ensuring flawless active drug uniformity down to the microgram across millions of compressed units.

• Validated In-Vitro Dissolution Kinetics: Every single export production batch physically undergoes strict Automated Multi-pH Dissolution Profiling, chemically validating that our generic tablets match the exact kinetic release curves and bioequivalence requirements of global innovator references (such as Leponex / Clozaril).

Primary Indications

• Refractory Psychiatry: Treatment of severely ill Treatment-Resistant Schizophrenia patients who fail to respond acceptably to standard, non-atypical antipsychotic drugs.

• Suicidal Behavior Reduction: Long-term reduction in the risk of recurrent Suicidal Behavior in patients presenting with Schizophrenia or Schizoaffective disorder.

Usage Instructions

• The Absolute Slow Titration Rule: Take the tablet orally with water. It can be administered consistently either with or without food. To completely prevent severe orthostatic hypotension, the titration schedule must initiate slowly (e.g., 12.5 mg once or twice on day 1, followed by 25 mg on day 2, before scaling up progressively by 25 mg daily).

• The Mandatory Blood Monitoring System: Advise clinical and retail network distribution hubs that Clozapine cannot be dispensed without absolute confirmation of regular hematological testing. It is clinically mandatory to track Absolute Neutrophil Counts (ANC) weekly for the first 6 months, bi-weekly for the next 6 months, and monthly thereafter to protect against blood disorders.

• The Sedation Dosing Offset: Clozapine displays high affinity for central $\text{H}_{1}$ and alpha-1 receptors, causing substantial daytime drowsiness during the initial phase. It is clinically recommended to allocate the larger portion of the split daily dose at bedtime.

Safety Warning: HIGH-POTENCY REGULATED ATYPICAL ANTIPSYCHOTIC. For Psychiatry Specialist Supervision Only. The Boxed Warning Matrix (Agranulocytosis): Clozapine can chemically induce a severe, life-threatening drop in white blood cells known as Severe Neutropenia / Agranulocytosis. If a patient’s Absolute Neutrophil Count ($ANC$) drops below $1500/\mu\text{L}$, physical administration must be halted immediately to prevent fatal systemic infection. Myocarditis & Seizure Alert: May chemically induce rare but fatal eosinophilic myocarditis or dose-dependent seizures; permanently discontinue if cardiomyopathy is suspected. Contraindications: Absolute contraindications in patients presenting with pre-existing bone marrow suppression, unmonitored leukopenia/agranulocytosis history, severe uncompensated hepatic or renal failure, severe central nervous system depression, or known hypersensitivity to dibenzodiazepine matrices.

Controlled Global Supply Chain & CDMO Licensing

Healthy Life Pharma Private Limited and Healthy Inc provide complete, internationally validated Third-Party Contract Manufacturing (CDMO Services) and bulk private-label export supply for the entire Clozapine dosage spectrum. Operating under strict narcotics and controlled psychotropic clearances, we handle all mandatory cross-border documentation (Official Ministry of Health Psychotropic Import Permits, Central Bureau of Narcotics – CBN Export Licenses, WHO-GMP Certificate, COPP, COA, and Complete CTD Format Dossier sets) for seamless customs entry and rapid national registration.

Commercial & Bulk Procurement Inquiries:

• Corporate Head Office: Mumbai, Maharashtra, India

• Primary Manufacturing Base: Boisar, Maharashtra, India

• WhatsApp / Direct Regulatory Helpline: +91 7710003340

• Controlled Substances Registry Email: info@healthyinc.co.in